Literature DB >> 15489908

Src family kinases, key regulators of signal transduction.

Sarah J Parsons1, J Thomas Parsons.   

Abstract

The Src family of protein tyrosine kinases (SFKs) plays key roles in regulating signal transduction by a diverse set of cell surface receptors in the context of a variety of cellular environments. SFKs have evolved many ingenious molecular strategies to couple receptors with the cytoplasmic signaling machinery. The contributions to this issue of ONCOGENE describe how this machinery regulates fundamental cellular processes, including cell growth, differentiation, cell shape, migration and survival, and specialized cell signals. The pleiotropic functions of Src and Src family members underscore the importance of these kinases and explain why many of the members of this family have been identified as cellular oncogenes. In this volume, we have attempted to provide the reader with an overview of the current understanding of the function of Src family kinases in the regulation of selected cellular signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15489908     DOI: 10.1038/sj.onc.1208160

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  343 in total

1.  Expression and purification of Src-family kinases for solution NMR studies.

Authors:  Andrea Piserchio; David Cowburn; Ranajeet Ghose
Journal:  Methods Mol Biol       Date:  2012

2.  Phase II study of saracatinib (AZD0530) for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).

Authors:  Matthew G Fury; Shrujal Baxi; Ronglai Shen; Katherine W Kelly; Brynna L Lipson; Diane Carlson; Hilda Stambuk; Sofia Haque; David G Pfister
Journal:  Anticancer Res       Date:  2011-01       Impact factor: 2.480

Review 3.  Cell competition and its implications for development and cancer.

Authors:  Yoichiro Tamori; Wu-Min Deng
Journal:  J Genet Genomics       Date:  2011-09-21       Impact factor: 4.275

Review 4.  Ultra-low-level laser therapy.

Authors:  Luigi Baratto; Laura Calzà; Roberto Capra; Michele Gallamini; Luciana Giardino; Alessandro Giuliani; Luca Lorenzini; Silvano Traverso
Journal:  Lasers Med Sci       Date:  2010-09-18       Impact factor: 3.161

5.  Phosphorylation of Trask by Src kinases inhibits integrin clustering and functions in exclusion with focal adhesion signaling.

Authors:  Danislav S Spassov; Ching Hang Wong; Natalia Sergina; Deepika Ahuja; Michael Fried; Dean Sheppard; Mark M Moasser
Journal:  Mol Cell Biol       Date:  2010-12-28       Impact factor: 4.272

6.  Apoptosis-associated tyrosine kinase 1 inhibits growth and migration and promotes apoptosis in melanoma.

Authors:  Shuang Ma; Brian P Rubin
Journal:  Lab Invest       Date:  2014-03-03       Impact factor: 5.662

7.  SRC family kinase inhibition as a novel strategy to augment melphalan-based regional chemotherapy of advanced extremity melanoma.

Authors:  Yoshihiro Tokuhisa; Michael E Lidsky; Hiroaki Toshimitsu; Ryan S Turley; Georgia M Beasley; Tomio Ueno; Ketan Sharma; Christina K Augustine; Douglas S Tyler
Journal:  Ann Surg Oncol       Date:  2013-11-27       Impact factor: 5.344

8.  Cooperative activation of Src family kinases by SH3 and SH2 ligands.

Authors:  Shalini S Yadav; W Todd Miller
Journal:  Cancer Lett       Date:  2007-08-24       Impact factor: 8.679

9.  The focal complex of epithelial cells provides a signalling platform for interleukin-8 induction in response to bacterial pathogens.

Authors:  Tyson P Eucker; Derrick R Samuelson; Mary Hunzicker-Dunn; Michael E Konkel
Journal:  Cell Microbiol       Date:  2014-06-02       Impact factor: 3.715

10.  JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines.

Authors:  Kian Kani; Carolina Garri; Katrin Tiemann; Paymaneh D Malihi; Vasu Punj; Anthony L Nguyen; Janet Lee; Lindsey D Hughes; Ruth M Alvarez; Damien M Wood; Ah Young Joo; Jonathan E Katz; David B Agus; Parag Mallick
Journal:  Mol Cancer Ther       Date:  2017-05-31       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.